Although further efforts are required to understand better the interplay among P2X7 variants in cancer evolution and in the tumor–host interplay, we firmly believe that this investigation field will be fertile in the years to come and pave the way for the testing of P2X7 targeting drugs in oncology. The gene discussed is P2RX7; the disease is neoplasm.